Cargando…
Long-term treatment with romiplostim and treatment-free platelet responses in children with chronic immune thrombocytopenia
Children with immune thrombocytopenia for ≥6 months completing a romiplostim study received weekly subcutaneous romiplostim (1-10 μg/kg targeting platelet counts of 50-200×10(9)/L) in this extension to examine romiplostim’s long-term safety and efficacy. Sixty-five children received romiplostim for...
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Ferrata Storti Foundation
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6821612/ https://www.ncbi.nlm.nih.gov/pubmed/30846500 http://dx.doi.org/10.3324/haematol.2018.202283 |